Several specific molecular alterations play crucial roles in the carcinogenesis of ESCC or BAC, with tumor cell aneuploidy and p53 mutations being major hallmarks of both ESCC and BAC [3-5]. The gene discussed is TP53; the disease is minimally invasive lung adenocarcinoma.